In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease

(E)-(S)-4-((S)-2-{3-[(5-methyl-isoxazole-3-carbonyl)-amino]-2-oxo-2H-pyridin-1-yl}-pent-4-ynoylamino)-5-((S)-2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester (Compound 1) is a novel, irreversible inhibitor of human rhinovirus (HRV) 3C protease {inactivation rate constant (K(obs)/[I]) of 223,000...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Patick, Amy K., Brothers, Mary A., Maldonado, Fausto, Binford, Susan, Maldonado, Oscar, Fuhrman, Shella, Petersen, Annkatrin, Smith, George J., Zalman, Leora S., Burns-Naas, Leigh Ann, Tran, Jonathan Q.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2005
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1140523/
https://ncbi.nlm.nih.gov/pubmed/15917520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.6.2267-2275.2005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados